Patient
SITE013-0256
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE013 (USA) (Dr. Clarke)
consented 2026-07-01
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 1 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-03-08 (study day 61); relationship: RELATED
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-02-13 (study day 38); relationship: not assessed
Grade 1 Anaemia — outcome: UNKNOWN; onset 2023-01-08 (study day 2); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.